Phase II study of EC followed by Nab-paclitaxel as neoadjuvant chemotherapy for HER2 negative with lymph node metastases
Phase 2
Recruiting
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000010685
- Lead Sponsor
- Saitama Medical Center,Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)History of hypersensitivity reaction 2)Active another cancer 3)Other severe complications, such as uncontrolled diabetes mellitus, uncontrolled angina, myocardial infarction within 6 months, heart failure. 4)Severe mental disorder 5)Sever bone marrow suppression, renal dysfunction, liver dysfunction 6)Body cavity fluid 7)Active infection or potentiality infection 8)Pregnant or lactating women, women who are capable of pregnancy, intend to get pregnant 9)Judged ineligible based on physicians' decision
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method